When Treating Peripheral Artery Disease, Prepare for the Worst, But Hope for the BEST (SFA).

Competing Interests: Funding Support and Author Disclosures Dr Biondi-Zoccai has served as a consultant for Amarin, Balmed, Cardionovum, Crannmedical, Endocore Lab, Eukon, Guidotti, Innovheart, Meditrial, Microport, Opsens Medical, Terumo, and Translumina outside the present work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.